Eicosanoids in inflammation in the blood and the vessel
A Yamaguchi, E Botta, M Holinstat - Frontiers in pharmacology, 2022 - frontiersin.org
Polyunsaturated fatty acids (PUFAs) are structural components of membrane phospholipids
in cells. PUFAs regulate cellular function through the formation of derived lipid mediators …
in cells. PUFAs regulate cellular function through the formation of derived lipid mediators …
Platelet signaling and disease: targeted therapy for thrombosis and other related diseases
J Yeung, W Li, M Holinstat - Pharmacological reviews, 2018 - ASPET
Platelets are essential for clotting in the blood and maintenance of normal hemostasis.
Under pathologic conditions such as atherosclerosis, vascular injury often results in …
Under pathologic conditions such as atherosclerosis, vascular injury often results in …
[HTML][HTML] The biological role of arachidonic acid 12-lipoxygenase (ALOX12) in various human diseases
Z Zheng, Y Li, G Jin, T Huang, M Zou, S Duan - Biomedicine & …, 2020 - Elsevier
ALOX12 encodes arachidonic acid 12-lipoxygenase that acts on different polyunsaturated
fatty acid substrates to produce biologically active lipid mediators including eicosanes and …
fatty acid substrates to produce biologically active lipid mediators including eicosanes and …
Microvascular thrombosis: experimental and clinical implications
MA Bray, SE Sartain, J Gollamudi, RE Rumbaut - Translational Research, 2020 - Elsevier
A significant amount of clinical and research interest in thrombosis is focused on large
vessels (eg, stroke, myocardial infarction, deep venous thrombosis, etc.); however …
vessels (eg, stroke, myocardial infarction, deep venous thrombosis, etc.); however …
Regulation of platelet function and thrombosis by omega-3 and omega-6 polyunsaturated fatty acids
R Adili, M Hawley, M Holinstat - Prostaglandins & other lipid mediators, 2018 - Elsevier
Thrombosis is the most common underlying pathology responsible for morbidity and
mortality in cardiovascular disease (CVD). Platelet adhesion, activation, and aggregation …
mortality in cardiovascular disease (CVD). Platelet adhesion, activation, and aggregation …
Synthesis and significance of arachidonic acid, a substrate for cyclooxygenases, lipoxygenases, and cytochrome P450 pathways in the tumorigenesis of glioblastoma …
J Korbecki, E Rębacz-Maron, P Kupnicka, D Chlubek… - Cancers, 2023 - mdpi.com
Simple Summary Glioblastoma multiforme is a brain tumor with a very unfavorable
prognosis, where the vast majority of patients do not survive a year after diagnosis. One line …
prognosis, where the vast majority of patients do not survive a year after diagnosis. One line …
First selective 12-LOX inhibitor, ML355, impairs thrombus formation and vessel occlusion in vivo with minimal effects on hemostasis
Objective—Adequate platelet reactivity is required for maintaining hemostasis. However,
excessive platelet reactivity can also lead to the formation of occlusive thrombi. Platelet 12 …
excessive platelet reactivity can also lead to the formation of occlusive thrombi. Platelet 12 …
The expansive role of oxylipins on platelet biology
J Yeung, M Hawley, M Holinstat - Journal of molecular medicine, 2017 - Springer
In mammals, three major oxygenases, cyclooxygenases (COXs), lipoxygenases (LOXs), and
cytochrome P450 (CYP450), generate an assortment of unique lipid mediators (oxylipins) …
cytochrome P450 (CYP450), generate an assortment of unique lipid mediators (oxylipins) …
Platelet ACKR3/CXCR7 favors antiplatelet lipids over an atherothrombotic lipidome and regulates thromboinflammation
M Cebo, K Dittrich, X Fu, MC Manke… - Blood, The Journal …, 2022 - ashpublications.org
Platelet ACKR3/CXCR7 surface expression is enhanced and influences prognosis in
coronary artery disease (CAD) patients, who exhibit a distinct atherothrombotic platelet …
coronary artery disease (CAD) patients, who exhibit a distinct atherothrombotic platelet …
Antiplatelet strategies: past, present, and future
L Stanger, A Yamaguchi, M Holinstat - Journal of Thrombosis and …, 2023 - Elsevier
Antiplatelet therapy plays a critical role in the prevention and treatment of major
cardiovascular diseases triggered by thrombosis. Since the 1900s, significant progress in …
cardiovascular diseases triggered by thrombosis. Since the 1900s, significant progress in …